Interesting reading on the competition - multiple FAK inhibitors in clinical trials. Few phase 1s and 2s. A reminder there's no time to waste here!
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-27
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.004(6.78%) |
Mkt cap ! $14.93M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.5¢ | $74.87K | 1.356M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 507325 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 12488 | 1 |
View Market Depth
| Last trade - 11.37am 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.7¢ |
Change
-0.004 ( 1.72 %) |
||||
| Open | High | Low | Volume | ||
| 5.7¢ | 5.7¢ | 5.5¢ | 183992 | ||
| Last updated 11.47am 21/05/2024 ? | |||||
| ATX (ASX) Chart |